Insmed Inc (INSM)
72.48
-0.39
(-0.54%)
USD |
NASDAQ |
Sep 27, 16:00
72.45
-0.03
(-0.04%)
After-Hours: 20:00
Insmed Cash and Short Term Investments (Quarterly): 1.247B for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 1.247B |
March 31, 2024 | 595.73M |
December 31, 2023 | 780.45M |
September 30, 2023 | 785.95M |
June 30, 2023 | 917.77M |
March 31, 2023 | 998.68M |
December 31, 2022 | 1.148B |
September 30, 2022 | 513.30M |
June 30, 2022 | 554.87M |
March 31, 2022 | 635.12M |
December 31, 2021 | 716.78M |
September 30, 2021 | 846.56M |
June 30, 2021 | 928.33M |
March 31, 2021 | 409.75M |
December 31, 2020 | 532.76M |
September 30, 2020 | 588.75M |
June 30, 2020 | 641.91M |
March 31, 2020 | 428.94M |
December 31, 2019 | 487.43M |
September 30, 2019 | 535.63M |
June 30, 2019 | 601.26M |
March 31, 2019 | 420.23M |
December 31, 2018 | 495.07M |
September 30, 2018 | 567.57M |
June 30, 2018 | 634.33M |
Date | Value |
---|---|
March 31, 2018 | 686.58M |
December 31, 2017 | 381.16M |
September 30, 2017 | 430.68M |
June 30, 2017 | 91.06M |
March 31, 2017 | 125.84M |
December 31, 2016 | 162.59M |
September 30, 2016 | 200.52M |
June 30, 2016 | 223.11M |
March 31, 2016 | 252.87M |
December 31, 2015 | 282.88M |
September 30, 2015 | 310.97M |
June 30, 2015 | 335.03M |
March 31, 2015 | 134.55M |
December 31, 2014 | 159.23M |
September 30, 2014 | 167.31M |
June 30, 2014 | 82.70M |
March 31, 2014 | 101.25M |
December 31, 2013 | 113.89M |
September 30, 2013 | 128.02M |
June 30, 2013 | 76.78M |
March 31, 2013 | 81.61M |
December 31, 2012 | 92.94M |
September 30, 2012 | 89.75M |
June 30, 2012 | 73.14M |
March 31, 2012 | 70.78M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
409.75M
Minimum
Mar 2021
1.247B
Maximum
Jun 2024
714.69M
Average
638.52M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Fulcrum Therapeutics Inc | 273.78M |
Eli Lilly and Co | 3.364B |
Bioventus Inc | 31.99M |
Entrada Therapeutics Inc | 469.75M |
NovaBay Pharmaceuticals Inc | 0.751M |